Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine. [electronic resource]
Producer: 20080602Description: 285-9 p. digitalISSN:- 0301-0430
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- therapeutic use
- Bendamustine Hydrochloride
- Drug Therapy, Combination
- Glomerulonephritis, Membranoproliferative -- complications
- Humans
- Immunologic Factors -- therapeutic use
- Leukemia, Lymphocytic, Chronic, B-Cell -- complications
- Male
- Middle Aged
- Nephrotic Syndrome -- drug therapy
- Nitrogen Mustard Compounds -- therapeutic use
- Remission Induction
- Rituximab
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.